Bach P, Reinhard I, Koopmann A, Bumb JM, Sommer WH, Vollstädt-Klein S, Kiefer F. Test-retest reliability of neural alcohol cue-reactivity: Is there light at the end of the magnetic resonance imaging tube?. Addict Biol. 2022 27(1):e13069. Epub 2021 Jun 15.
Bach P, Schuster R, Koopmann A, Vollstädt-Klein S, Spanagel R, Kiefer F. Plasma calcium concentration during detoxification predicts neural cue-reactivity and craving during early abstinence in alcohol-dependent patients. Eur Arch Psychiatry Clin Neurosci. 2022 272(2):341-348. Epub 2021 Feb 25.
Bumb JM, Wisch C, Riegler A, Schuster R, Reinhard I, Frischknecht U, Kiefer F, Koopmann A. Yoga als Add-on Therapie zu Dialektisch Behavioraler Therapie Sucht - Effekte auf die innere Anspannung von Patien:innen mit Substanzgebrauchsstörung und komorbider Borderline-Persönlichkeitsstörung. Suchttherapie. 2022 23(04):184-191.
Georgiadou E, Müller A, Koopmann A, Leménager T, Hillemacher T, Kiefer F. Changes in gambling behavior during the COVID-19 lockdown in Germany. Int Gambling Studies. 2022 22(1):45-62.
Gerhardt S, Eidenmueller K, Hoffmann S, Bekier NK, Bach P, Hermann D, Koopmann A, Sommer WH, Kiefer F, Vollstädt-Klein S. A History of Childhood Maltreatment Has Substance- and Sex-Specific Effects on Craving During Treatment for Substance Use Disorders. Front Psychiatry. 2022 13:866019.
Vetter S, Thomas BC, Krisam J, Limprecht R, Klose C, Stenger M, Pourbaix M, Ries M, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Bach P. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial. BMJ Open. 2022 12(4):e059672.
Wetzel L, Pourbaix M, Riegler A, Pfeifer AM, Reinhard I, Hoffmann S, Vollstädt-Klein S, Kiefer F, Sommer WH, Bumb JM, Back P, Koopmann A. G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study. Trials. 2022 23(1):693.